Table 1.
Clinicopathologic characteristics of patients who underwent extended hepatectomy.
| Variables | Total |
|---|---|
| (n = 213) | |
| Age (years) | 60.8 ±11.7 |
| Gender | |
| Female/male | 108/105 |
| BMI (kg/m2) | 25.53 ± 4.44 |
| ASA score | |
| Class 1 | 4 (2.5%) |
| Class 2 | 76 (46.9%) |
| Class 3 | 82 (50.6%) |
|
| |
| Cirrhosis | |
| Yes | 7 (3.2%) |
| Indication of extended hepatectomy | |
| Benign liver disease | 9 (4.2%) |
| Primary malignancy | 123 (57.7%) |
| Cholangiocarcinoma | 105 (85.4) |
| Hepatocellular carcinoma | 18 (14.6%) |
| Metastatic disease | 81 (38.0%) |
| Preoperative chemotherapy | |
| Yes | 73 (35.8%) |
| Preoperative platelet count (x 109/L) | |
| Mean (SD) | 300.1 ± 121.5 |
|
| |
| Intraoperative blood loss (ml) | 1638.21 ± 1535.49 |
| Transfusion of RBC | |
| Patient | 60 (31.1%) |
| Unit | 1.52 ± 3.34 |
| Transfusion of FFP | |
| Patient | 44 (22.8%) |
| Unit | 1.43 ± 3.64 |
| Operation time (min) | 293.78 ± 115.15 |
|
| |
| PHLF a | 56 (26.3%) |
| Grade A |
16 (28.6%) |
| Grade B |
14 (25.0%) |
| Grade C | 26 (46.4%) |
| Major morbidity b | 57 (26.8%) |
| ICU stay (days) | 8.14 ± 13.47 |
| Hospitalization (days) | 23.43 ± 16.68 |
| 30-day mortality | 24 (11.3%) |
BMI: body mass index; ASA: American Society of Anesthesiologists; SD: standard deviation; RBC: red blood cells; FFP: fresh-frozen plasma; PHLF: posthepatectomy liver failure; ICU: intensive care unit.
a Based on the ISGLS definition.
b Grades III and IV based on the Clavien-Dindo classification.